Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

KL1333

Home DrugsKL1333

Investigational

Small Molecule

KL1333

Unknown Manufacturer

Generate AI report

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Technical identifiers

Chemical Formula: C₁₄H₁₂N₂O₂
CAS Number: 1800405-30-4
UNII ID: NA2ZOL5UGM

Patents

One entry per invention. Patent families filed in the US, EP, WO and CN offices.

KL1333 FOR USE IN MEDICINE
EP 4340831 A1Applicant: ABLIVA ABPriority: 2021
CN
EP
US
WO
4 publications
KL1333 composition and application thereof in preparation of tumor treatment medicine
CN 119033774 AApplicant: UNIV MACAUPriority: 2024
CN
KL1333 derivative compound as well as preparation method and application thereof
CN 122233990 AApplicant: UNIV MACAUPriority: 2026
CN